Introduction
Campylobacter jejuni is one of the most important foodborne pathogens in the world. Although it primarily causes self-limiting diarrhea, C. jejuni is also associated with severe neuropathologic disorders such as Guillain-Barré and Reiter syndromes (1) . Upon consuming C. jejuni-contaminated water or food items such as poultry or raw milk (2) , the pathogen interacts with the host cells. Adherence is a key step in the establishment of the infection (3) . In this process, fibronectin-binding protein (CadF), which is expressed in all C. jejuni and C. coli strains (4), plays an important role by binding to the cell matrix protein, fibronectin (5) . Invasion antigen B (CiaB), the first secreted factor identified in C. jejuni, has an important role in invasion and has been identified as essential for the secretion of other Cia proteins (4) .
Recent observations of the antibiotic resistance for some Campylobacter strains indicate a need to develop new approaches to block not only growth but also key steps during the infection process (6) . Compounds present in plants have been historically studied for their antioxidant and pharmacological activities. Citrus plants are among the world's major fruit crops and can be consumed fresh or as processed products. Specifically, extracts from the Citrus species show a wide spectrum of antimicrobial activity (7) and hold potential for use in antioxidant-based therapies against cancer, inflammation, and heart disease (8) .
Citrus oils and derivatives are generally recognized as safe by the Food and Drug Administration. The juice industry wastes large amounts of fruit byproducts, especially seeds, bagasse, and peels (50-65% of total fruit weight) (9, 10) . Use of Citrus byproducts is growing and studies suggest their potential use as alternatives to prevent fatty acid deterioration in the food industry (9) . These byproducts contain high amounts of phenolic compounds such as phenolic acids and flavonoids (which are responsible for the antioxidant activity, 11) and are present in high concentrations (up to 15%) in Citrus peels and seeds (9) . Although the content of these compounds can be influenced by many factors and could vary during harvest, postharvest, and among species (12) (13) (14) , studies about their use as alternatives for effective antimicrobials have increased because of the development of antibiotic resistance by various microorganisms, including the Campylobacter species (6) .
Pathogenesis of Campylobacter is initiated with adherence to intestinal epithelial cells, followed by internalization by bacterial invasion. Once inside the cell, a cytolethal distending toxin is produced that results in host cell death (3) . Although Citrus extracts have been tested for their ability to inhibit the growth of C. jejuni (15) (16) (17) , little information is available about their effects on pathogenesis. Therefore, the purpose of this study was to evaluate the influence of Citrus byproduct extracts on the adherence and invasion processes of C. jejuni to HeLa cells and to assess the relative expression levels of the genes involved in these processes (cadF and ciaB). In addition, the antioxidant activity of these compounds was determined.
Materials and Methods
Campylobacter strains and growth conditions The strain used in this study, C. jejuni NCTC 11168, was obtained from the American Type Culture Collection (Manassas, VA, USA). The C. jejuni strain NADC 5653 was isolated from chicken (provided by Dr. Irene Wesley, USDA-ARS-NADC, Ames, IA, USA). C. jejuni strains 180ip and 238ip were isolated from patients with diarrhea (provided by Dr. Guillermo Ruiz-Palacios, National Institute of Medical Sciences and Nutrition, Mexico City, Mexico). The Campylobacter strains were maintained at −80 o C in 20% glycerol brain-heart infusion broth (Difco Laboratories, Sparks, MD, USA) supplemented with 0.6% yeast extract. An aliquot of each extract was used for the dry weight determination. All extracts were stored at 4 o C in a dark environment until required for use (usually ≤12 weeks). Antimicrobial activity of each extract was evaluated each month during this period by the well-diffusion test (19) .
Effect of sub-inhibitory concentrations of Citrus byproduct extracts on C. jejuni growth In the previous studies from our laboratory, we obtained a minimum bactericidal concentration (MBC) against C. jejuni strains of 130-225 μg/mL for C. limon, 275-325 μg/mL for C. aurantium, and 150-250 μg/mL for C. medica byproduct extracts. MBCs varied depending on the analyzed strain (16) . In this study, we determined the effects of the sub-inhibitory concentrations (lower than MBC) of the byproduct extracts on C. jejuni growth with the purpose of using these concentrations for adherence and invasion assays.
Tubes containing 5 mL of MHB were inoculated with 50 μL of fresh C. jejuni culture (A Adherence assay Bacterial cultures of four C. jejuni strains were ) for 3 h to enable the bacteria to attach to the HeLa cells. The monolayers were washed three times with 500 μL of phosphate-buffered saline (PBS) to eliminate the nonattached bacteria. The adhered bacteria were detached by adding 200 μL of 0.5% sodium deoxycholate solution (Sigma-Aldrich, St. Louis, MO, USA) and counted by a plate count using MHS agar. Bacteria treated with miliQ water were used as a control. Invasion assay The procedure described for the adherence assay with a few modifications was followed. After infection, the HeLa cells were washed with PBS and supplemented with fresh PBS containing 1% FBS and 150 μg/mL gentamicin (to kill the remaining viable attached bacteria). The cells were incubated for 1 h, washed twice with PBS, and lysed with 0.5% deoxycholate. The viable intracellular bacteria were quantitated using the plate count method. Results were expressed as the percentage of bacteria adhered in relation to the initial inoculum (%A) and the percentage of invasive bacteria in relation to the adhered bacteria (Ratio I/A) (21).
Quantitative PCR for adherence and invasion genes To evaluate the effects of the Citrus byproduct extracts on the expression levels of cadF (adherence, Table 2 ), ciaB (invasion, Table 2 ), and housekeeping gene glyA (housekeeping genes are involved in basic cell maintenance and, therefore, are expected to maintain constant expression levels in all cells and conditions), RNA was isolated from the bacteria as reported in previous studies (16, 22) Although this method seems to be simpler than the Livak method, the results are essentially the same and the expression is normalized. The expression was determined for both treated and untreated cells.
Bioactive compound and antioxidant activity assays Total phenols and flavonoids: The total phenol content in the Citrus byproduct extracts was determined by the colorimetric FolinCiocalteu reagent using gallic acid as the standard (26) . Briefly, 50 μL of hydrophilic Citrus byproduct extracts (adjusted to 1.0 mg/L) were added to 3 mL of deionized water plus 0.25 mL of Folin-Ciocalteu reagent (1 N, Sigma-Aldrich). After 5 min, 0.75 mL of 20% Na 2 CO 3 solution was added and deionized water was added to reach a total volume of 5 mL. After incubation at room temperature for 30 min, the phenol concentration was measured spectrophotometrically at 760 nm and reported as mg of gallic acid equivalent (GAE) per g of dry weight.
The total flavonoid content was measured by the aluminum chloride reaction as reported by Zhishen et al. (27) . Citrus byproduct extracts (1 mL) were mixed with 4 mL of deionized H water was added to reach a total volume of 10 mL. Absorbance was measured at 415 nm using a UV spectrophotometer (mod. 6405; Jenwey, Staffordshire, UK). The total flavonoid content was expressed on a dry-weight basis as the milligrams of quercetin equivalents per gram (DW). Antioxidant activity: The radical scavenging activity was determined using the 2,2-diphenyl-1-picrylhydrazyl (DPPH • ) method and the Trolox-equivalent antioxidant capacity (TEAC, 28). DPPH
• was analyzed using the method described by Kedare and Singh (29) with some modifications. A stock solution of DPPH Statistical analyses All experiments were conducted at least three times in three separate experiments. Statistical analyses were performed using SPSS software (version 10.0, SPSS Inc., Chicago, IL, USA). Results were analyzed using the ANOVA test, followed by a post-hoc test using the multiple-comparison Turkey method. Spearman rank analyses were used to determine the correlation between the antioxidant activity of the extracts and the adherence and invasion of C. jejuni in HeLa cells. Differences between the means were considered significant if p≤0.05.
Results and Discussion
Citrus byproduct extracts reduce C. jejuni adherence and invasion Addition of sub-inhibitory concentrations of Citrus byproduct extracts did not cause any significant reduction in the growth of any tested strain (11168, 5653, 238ip, and 180ip) than that achieved for untreated controls (Fig. 1) . Therefore, 75% of the MBC was used for all subsequent assays (Table 1) .
Strains tested without Citrus byproduct extracts showed different percentages of adherence (13.8, 5.4, 2.2, and 0.05% for strains 11168, 5653, 238ip, and 180ip respectively; Table 3 ). When the cells were treated with Citrus byproduct extracts, the adherence was reduced compared with that of the control (p≤0.05) in almost all cases, except when strain 180ip was treated with C. limon or C. aurantium (Table 3) . The Spearman rank analysis indicated a correlation between the antioxidant activity (DPPH) and adherence (rho 0.569; p=0.026) for C. jejuni 180ip; however, this correlation was not observed for the other strains analyzed. Also, a correlation was detected between the antioxidant activity (TEAC) and adhesion for C. jejuni 11168 (rho 0.56; p=0.020) and C. jejuni 238ip (rho 0.58; p=0.027). In general, the ratio I/A bacteria varied among different strains (Table 3) . Invasion was lower (p≤0.05) for all treatments compared with that observed for the control (Table 3) . As observed for adhesion assays, I/A ratio showed a correlation with the antioxidant activity measured by DPPH in C. jejuni 180ip (rho=0.700; p=0.003). A similar correlation was observed between the antioxidant activity (TEAC) and the I/A ratio for C. jejuni 238ip (rho 0.644; p=0.009). For the case of the C. jejuni strain 5653, an inverse Fig. 1 . Viable Campylobacter jejuni NCTC 11168 cells treated with sub-inhibitory concentrations of Citrus byproduct extracts. Concentrations used for C. limon were 168, 113, and 56 mg/mL (corresponding to 75, 50, and 25% MBC, respectively), for C. auranticum 244, 163, and 81 mg/mL (75, 50, and 25% MBC, respectively), and for C. medica 188, 125, and 63 mg/mL (75, 50, and 25% MBC, respectively). correlation was detected (rho=0.719; p=0.002) wherein a decreasing ratio I/A was observed with respect to the antioxidant activity of the extracts analyzed. Statistical analyses did not show differences between the effects produced by various extracts.
Citrus byproduct extracts reduce cadF and ciaB gene expression Expression levels of cadF (adhesion) and ciaB (invasion) genes were measured using the housekeeping gene glyA as a reference. Expression levels of cadF and ciaB were reduced (p≤0.05) in all cases compared with that for the control. The results of gene expression, varied depending on the analyzed strain and type of Citrus byproduct extract. No differences in gene expression were observed between the analyzed extracts, except for cadF in C. jejuni 180ip when treated with C. limon and ciaB in C. jejuni 238ip when treated with C. aurantium (Fig. 2) .
Bioactive compounds and antioxidant activities of Citrus byproduct extracts Phenolic compounds: Differences (p≤0.05) were observed in the phenolic and total flavonoid contents of the extracts. In general, C. aurantium byproducts contained the highest levels of phenolic compounds (Fig. 3) and showed the maximum reduction of adherence (except for C. jejuni 180 ip). Total phenolic contents of C. aurantium, C. limon, and C. medica byproduct extracts were 92.0±4.8, 41.7±13.1, and 25.8±2.8 mg GAE/g of DW, respectively. Total flavonoid contents of the Citrus byproduct extracts exhibited differences, with the highest content being found in C. aurantium (161.09±0.2 mg QE/g), followed by C. limon and C. medica (63.97±0.3 and 29.29±5.6 mg QE/g, respectively). Antioxidant capacities of Citrus byproduct extracts: The highest DPPH radical scavenging activity (p≤0.05) was detected for the byproduct extract of C. aurantium (90.1±0.6%), followed by the extracts of C. limon (44.6±1.2%) and C. medica (43.8±0.3%) (Fig. 4) . No significant differences were observed between C. limon and C. medica extracts. Antioxidant capacities differed (p≤0.05) among all Citrus byproduct extracts, with TEAC values of 15.8±0.4 μmol TE/g for C. aurantium, 19.8±0.1 μmol TE/g for C. limon, and 14.8±0.5 μmol TE/g for C. medica extracts (Fig. 4) .
In this study, the effects of Citrus byproduct extracts on the adherence and invasion processes in C. jejuni were determined and their total phenolic contents and antioxidant capacities were analyzed. As key steps in the development of C. jejuni infection, adherence and invasion correlate with the severity of the symptoms and infection (30, 31) . Campylobacter strains used in this study showed differences in both processes, consistent with that reported in previous studies describing such variability (2, 21) . However, adherence and invasion abilities appeared to be correlated in almost all cases, in contrast to that reported by previous studies showing that the invasion process is independent of adherence (20, 21) . Invasion and adhesion could be influenced by the cell lines that are used for in vitro assays and genetic factors (2, 20, 21) . In our experiments, the extents of adherence and invasion were reduced by treatment with Citrus byproduct extracts (Fig. 2) . Similarly, Pogaèar et al. (32) reported a reduction in C. jejuni invasiveness in the human fetal small intestine cell line when Alphinia katsumadai extracts were used. Genes ciaB and cadF encode the proteins involved in adherence and invasion. CiaB was first identified as an important secreted factor during invasion. CadF was the first described fibronectin-binding protein, playing a crucial role in the processes of adherence and colonization (4) . However, the exact roles of these proteins during infection are not well understood (4). Our results showed that the expression levels of ciaB and cadF varied among the strains (Fig. 2) .
We previously reported that the strain C. jejuni 238ip has low motility and the strain C. jejuni 180ip is non-motile (33) . As motility plays an important role in adherence and invasion (5), both strains were expected to have low adherence and invasion abilities. As we anticipated, the non-motile strain showed lower adherence and adherence/invasion ratios than the motile strain. However, CadF and CiaB mRNA may be expressed at low levels in the non-motile C. jejuni cells and may contribute to low rate of adherence and invasion abilities. After treating the strains with Citrus byproduct extracts, the relative expression levels of ciaB and cadF were significantly reduced in all strains. These results agree with those reported by Lee et al. (34) , who found that epigallocatechin gallate reduced the transcription of the major virulence genes in E. coli O157:H7. Likewise, Castillo et al. (16) reported a diminution of flaA-B expression in C. jejuni after treatment with Citrus extracts.
Phenolic compounds have been widely studied and their benefits to human health are well-known (8, 35) . Their protective activity has been mainly attributed to their free radical-scavenging abilities (36) . Citrus byproducts, particularly peels, potentially represent a rich source of natural flavonoids. Although abundant in the plant kingdom, several flavonoids (e.g., avanones, avanone glycosides, and polymethoxylated avones) are unique to Citrus fruits (37, 38) . We analyzed the variations in the total phenolic content and antioxidant activity among the three Citrus extracts.
Gorinstein et al. (39) evaluated the total polyphenol content of C. limon and C. sinensis peels, reporting high content of total polyphenols in lemons. Ghasemi et al. (40) examined the total phenol and flavonoid contents in C. aurantium peels (232.2 mg GAE/g, 7.7 mgQE/g DM) and C. limon peels (131 mg GAE/g DM, 16 .2 mgQE/g DM). Their reported values are higher than those reported in this study; however, the total flavonoid contents of byproducts from orange and lemon fruits were significantly higher in our study (41) .
Previous studies described high variation in the total polyphenol contents of Citrus fruits, which could be because of the non-uniform peel compositions (40) , differences in the extraction methods and solvents used, plant stress, geographical and climatic conditions, cultural practices, harvest time, and genotypic differences (42) . We determined the antioxidant capacities of total phenolics and flavonoids in the Citrus byproduct extracts using two methods, the DPPH radical scavenging method and the TEAC assay (43, 44) . The two methods were chosen because Citrus extracts may contain varying proportions of phenolic components, which may have different antioxidant capacities. Significant differences in TEAC and %RSA were observed among the extracts; however, correlations were found between the DPPH (% RSA) assay for total phenolic (R 2 =0.9448) and total flavonoid (R 2 =0.939) contents. The DPPH assay showed the highest correlation with all the analyzed bioactive compounds.
Taken together, our results show that Citrus byproduct extracts could be good alternatives for devising new strategies to control Campylobacter infections. Further research should focus on food models and in vivo assays to understand the behavior of bacteria in Fig. 4 . Antioxidant capacities (DPPH and TEAC) of the three Citrus byproduct extracts. Different letters above bars represent signicant differences (p<0.05) between Citrus peel extracts, whereas same letters represent no significant difference. Fig. 3 . Total phenolic and flavonoid contents of the three Citrus byproduct extracts.
